The compensation of patients injured in clinical trials

John M. Barton, Maureen S. Macmillan, Lindsay Sawyer | Journal of Medical Ethics | 1995


The problem of ‘no fault’ compensation for patients who suffer adverse effects as a result of their participation in clinical trials is discussed in the light of the guidelines issued by the Association of the British Pharmaceutical Industry (ABPI) and our recent experiences in reviewing protocols submitted to the local ethics of surgical research sub-committee. We have found a variety of qualifications being applied by pharmaceutical firms which are not in the spirit of the guidelines, let alone the interests of the patient, and we suggest a means whereby the patient can be assured of fair treatment in the event of ‘no fault’ injury.

Read full article

Bookmark the permalink.

Comments are closed.